EuropaBio Open Session 2012

13.06.2012

On June 13, 2012, EuropaBio held its annual AGM and open session at the Dominican Hotel, in Brussels. The programme included interesting speeches by European Commission officials concerning the future of the biotechnology sector as well as a presentation of the key findings of the EuropaBio/Ernst & Young report: ‘What Europe has to offer biotechnology companies- unraveling the tax, financial and regulatory framework’.

You can find the presentations of the event here.

 

The complete programme included:

Welcome address - Stephan Tanda, Chairman of EuropaBio, Member of the Board, Royal DSM

Future of European Research and Innovation policy - Robert-Jan Smits, Director General, DG Research & Innovation, European Commission

Importance of standardisation to gain product acceptance - Elke Anklam, Director of the Health and Consumer Protection Institute, Joint Research Centre, European Commission

What Europe has to offer biotechnology companies: unravelling the tax, financial and regulatory framework - Paul Fitzgerald, Global Life Science Tax Network, Ernst & Young

Closing remarks, Nathalie Moll, Secretary General, EuropaBio